Christopher Klein
2022
In 2022, Christopher Klein earned a total compensation of $367.2K as General Counsel & Secretary at RVL Pharmaceuticals plc, a 55% decrease compared to previous year.
Compensation breakdown
| Salary | $355,000 |
|---|---|
| Other | $12,200 |
| Total | $367,200 |
Klein received $355K in salary, accounting for 97% of the total pay in 2022.
Klein also received $12.2K in other compensation.
Rankings
In 2022, Christopher Klein's compensation ranked 4,824th out of 5,736 executives tracked by ExecPay. In other words, Klein earned more than 15.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,824 out of 5,736 | 16th |
Division Manufacturing | 2,678 out of 3,125 | 14th |
Major group Chemicals And Allied Products | 1,260 out of 1,416 | 11th |
Industry group Drugs | 1,185 out of 1,317 | 10th |
Industry Pharmaceutical Preparations | 867 out of 963 | 10th |
Source: SEC filing on April 24, 2023.
Klein's colleagues
We found three more compensation records of executives who worked with Christopher Klein at RVL Pharmaceuticals plc in 2022.
News
RVL Pharmaceuticals plc Former EVP, Research & Development Tina deVries' 2022 pay slips 19% to $561K
April 24, 2023
RVL Pharmaceuticals plc CEO Brian Markison's 2021 pay falls 63% to $1.4M
April 25, 2022
RVL Pharmaceuticals plc CEO Brian Markison's 2020 pay slips 12% to $3.8M
April 26, 2021
RVL Pharmaceuticals plc CEO Brian Markison's 2019 pay jumps 291% to $4.3M
April 20, 2020